Rapid Reversal of Anticoagulation with the specific Factor Xa Inhibitor Antidote Andexanet alfa (Ondexxya®) from Portola

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2020年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [31] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [32] REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES
    Bradshaw, Paige
    Philpott, Carolyn
    Droege, Christopher
    Droege, Molly
    Ernst, Neil
    Foertsch, Madeline
    Harger, Nicole
    Srinivasan, Vasisht
    Winter, Jessica
    Keegan, Shaun
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 450 - 450
  • [33] RISK FACTORS FOR THROMBOISCHEMIC COMPLICATIONS AFTER ANDEXANET ALFA REVERSAL OF FACTOR XA INHIBITORS
    Bradshaw, Paige
    Shouse, Tiffany
    Foertsch, Madeline
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [34] Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
    Rauch, Sebastian
    Mueller, Hans-Peter
    Dreyhaupt, Jens
    Ludolph, Albert C.
    Kassubek, Jan
    Althaus, Katharina
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [35] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan
    Toyoda, Kazunori
    Arakawa, Shuji
    Ezura, Masayuki
    Kobayashi, Rei
    Tanaka, Yoshihide
    Hasegawa, Shu
    Yamashiro, Shigeo
    Komatsu, Yoji
    Terasawa, Yuka
    Masuno, Tomohiko
    Kobayashi, Hiroshi
    Oikawa, Suzuko
    Yasaka, Masahiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (03) : 201 - 213
  • [36] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
  • [37] Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
    Benz, Alexander P.
    Xu, Lizhen
    Eikelboom, John W.
    Middeldorp, Saskia
    Milling, Truman J., Jr.
    Crowther, Mark
    Yue, Patrick
    Conley, Pamela
    Lu, Genmin
    Connolly, Stuart J.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 998 - 1005
  • [38] Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
    Bourdin, Matthieu
    Perrotin, Delphine
    Mathieu, Olivier
    Herve, Tristan
    Depasse, Francois
    Lu, Genmin
    Conley, Pamela B.
    Contant, Genevieve
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 795 - 801
  • [39] Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban
    Abuan, Irene
    Wong, Kristine H.
    Bolinske, Benjamin
    Hale, Katherine S.
    JOURNAL OF PHARMACY TECHNOLOGY, 2019, 35 (03) : 119 - 125
  • [40] Efficacy and safety of andexanet alfa for factor Xa inhibitor-associated intracranial haemorrhage
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Romoli, Michele
    Sarraj, Amrou
    Krogias, Christos
    Karapanayiotides, Theodoros
    Theodorou, Aikaterini
    Stefanou, Maria Ioanna
    Molina, Carlos A.
    Themistocleous, Marios
    Steiner, Thorsten
    Shoamanesh, Ashkan
    Palaiodimou, Lina
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2025,
12345